Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
AIMCompany Name
AIM IMMUNOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTAIM IMMUNOTECH INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
AIM - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ -6.55M | $ -16.17M | 0% |
| 3/31/2025 | $ -3.86M | $ -15.21M | 0% |
| 12/31/2024 | $ -1.32M | $ -17.32M | 0% |
| 9/30/2024 | $ 2.91M | $ -23.93M | -821.74% |
| 6/30/2024 | $ 6.1M | $ -28.05M | -459.6% |
| 3/31/2024 | $ 4.83M | $ -31.12M | -644.8% |
| 12/31/2023 | $ 10.23M | $ -28.96M | -283% |
| 9/30/2023 | $ 22.6M | $ -20.77M | -91.92% |
| 6/30/2023 | $ 30.14M | $ -19.34M | -64.19% |
| 3/31/2023 | $ 34.99M | $ -19.29M | -55.12% |
Key Performance Insights, Last 5 Years
- AIM IMMUNOTECH INC's latest trailing twelve months (TTM) ROE stands at -19.1%.
- Over the past 5 years, AIM IMMUNOTECH INC's average ROE has been -161.37%.
- The median ROE for AIM IMMUNOTECH INC during this period was -48.96%
- AIM IMMUNOTECH INC reached its highest ROE over the past 5 years at -19.1%.
- The lowest ROE recorded by AIM IMMUNOTECH INC in the same timeframe -821.74%
AIM IMMUNOTECH INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for AIM IMMUNOTECH INC is calculated as follows: Net Inc. Cmn. [ $ -11.67M ] / Equity [ $ 61.11M ]
(=) ROE [ -19.1% ] AIM - Return on Equity, Last 5 years
-821.74%
Minimum
Sep 30, 2024
-19.1%
Maximum
Sep 30, 2020
-161.37%
Average
-48.96%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |